首页> American journal of therapeutics> Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Akash,Kumar

第一单位： Medical Research Center, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.

作者： Akash,Kumar ^[1] ; Mariam,Shahabi ^[2] ; Saad Ahmed,Waqas ^[2] ; Nisha,Kumari ^[2] ; Nimurta,Madhwani ^[1] ; Raheel,Ahmed ^[3] ; Ram ^[1]

作者单位： Medical Research Center, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan. ^[1] Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan. ^[2] National Heart and Lung Institute, Imperial College, London, United Kingdom. ^[3]

DOI 10.1097/MJT.0000000000001968

PMID 40304630

发布时间 2026-01-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American journal of therapeutics

e113-e115页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

American journal of therapeutics

e113-e115页

检索历史清除

Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

American journal of therapeutics

相似文献

同项目论文

American journal of therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.

American journal of therapeutics

相似文献

同项目论文

American journal of therapeutics

相关期刊

检索历史清除